Thermo Fisher Scientific to Acquire Solventum’s Purification & Filtration Business for ~$4.1B
Shots:
- Thermo Fisher has entered into definitive agreement with Solventum to acquire its purification & filtration business for ~$4.1B in cash, adding value to its upstream and downstream biologics development & manufacturing
- Transaction is expected to close by the end of 2025, pending regulatory approval & customary closing conditions
- Solventum's purification and filtration unit has team of 2,500 spread globally and generated ~$1B in 2024. Solventum's P&F is complimentary to Thermofisher's cell culture media and single use technologies for biologics development
Ref: BusinessWire | Image: Thermo Fisher Scientific & Solventum
Related News:- Carlyle to Acquire Baxter International’s Vantive Kidney Care Segment for $3.8B
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Ridhi is an avid secondary researcher who follows trends in the biopharmaceutical and healthcare sectors to curate engaging content for the global audience. She works as a news editor at PharmaShots and loves to read books and explore new destinations.
